Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze CSPCY stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CSPCY investment potential.

What is CSPCY stock price today?

Get real-time CSPCY stock price, historical data, and price charts on Financhill. Track CSPCY performance with our advanced analysis tools.

Is CSPCY a good investment?

Evaluate CSPCY investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CSPCY stock?

To buy CSPCY stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CSPCY?

View detailed market capitalization data and company valuation metrics for CSPCY on our comprehensive analysis page.

What is the P/E ratio of CSPCY?

Use our fundamental analysis tools to view CSPCY P/E ratio and compare valuation metrics with industry peers.

What are CSPCY earnings?

View CSPCY earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

CSPC Pharmaceutical Group Ltd. 10K Form

Sell

CSPCY
CSPC Pharmaceutical Group Ltd.

Last Price:

$3.84

Seasonality Move:

13.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CSPCY News And Ratings

See the #1 stock for the next 7 days that we like better than CSPCY

CSPCY Financial Statistics

Sales & Book Value

Annual Sales:	$4B
Cash Flow:	$0
Price / Cash Flow:	25.44
Annual Sales:	$1.54
Price / Book:	13.45

Profitability

EPS (TTM):	0.18620
Net Income (TTM):	$534.1M
Gross Margin:	$2.8B
Return on Equity:	12.37%
Return on Assets:	9.96%

CSPC Pharmaceutical Group Ltd. Earnings Forecast

Key CSPC Pharmaceutical Group Ltd. Financial Ratios

The Gross Profit Margin over the past 22 years for CSPCY is 69.97%.
The Selling, General & Administrative Expenses for CSPCY have been equal to 33.58% of Gross Profit Margin.
The Research & Development expenses have been 17.89% of Revenue.
The Interest Expense is 1.01% of Operating Income.
The Net Earning history of CSPCY is 14.96% of Total Revenues.
Per Share Earnings over the last 22 years have been positive in 14 years.

CSPC Pharmaceutical Group Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	OTCM
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	CSPCY
Website:	cspc.com.hk

Debt

Debt-to-Equity Ratio:	0.01
Current Ratio:	2.27
Quick Ratio:	1.93

Price-to-Earnings

Trailing P/E Ratio:	18.74
Forward P/E Ratio:	0

CSPCY Technical Analysis vs Fundamental Analysis